TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis TherapyVanesa Nozal, Ana Martı́nez, Paula Santana et al.|Journal of Medicinal Chemistry|2022Cited by 45
Network pharmacology reveals multitarget mechanism of action of drugs to be repurposed for COVID-19Melissa Alegría‐Arcos, David Ramírez, Tábata Barbosa et al.|Frontiers in Pharmacology|2022Cited by 22